Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
NOT YET RECRUITING
NCT06599229
Perfusion Abnormalities in Hypertrophic Cardiomyopathy
Sponsor: University of Virginia
View on ClinicalTrials.gov
Summary
The purpose of this study is to investigate whether myocardial microvascular perfusion in patients with hypertrophic cardiomyopathy improved after initiation of cardiac myosin inhibitor therapy.
Official title: Myocardial Perfusion Abnormalities in Hypertrophic Cardiomyopathy
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
30
Start Date
2024-11-15
Completion Date
2028-12-01
Last Updated
2024-09-19
Healthy Volunteers
No
Conditions
Interventions
DIAGNOSTIC_TEST
myocardial contrast echo
Vasodilator stress myocardial contrast echocardiography will be performed at baseline and within 4 months of reaching target dose of a cardiac myosin inhibitor.